| Cvs Pharmacy #00638 | |
| 74 Lakeview Dr S, Gibbsboro, New Jersey 08026 | |
| (856) 783-6328 |
| Name | Cvs Pharmacy #00638 |
|---|---|
| Organization Name | New Jersey Cvs Pharmacy Llc |
| Location | 74 Lakeview Dr S, Gibbsboro, New Jersey 08026 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (856) 783-6328 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. reported today that top-line results from the one-year lorcaserin BLOOM-DM trial demonstrate statistically significant weight loss in obese and overweight patients with type 2 diabetes. In this trial, lorcaserin met all three co-primary efficacy endpoints. In addition, as described below, lorcaserin patients taking lorcaserin 10 mg twice daily (BID) achieved statistically significant improvements in multiple secondary endpoints, including HbA1c, as compared to patients randomized to placebo.
A new model based on measuring stress from daily hassles may help forecast future migraine headache attacks in those who develop them frequently.
The World Health Organization is pledging its support to the One Million Safe Schools and Hospitals Campaign launched yesterday in Manila. The goal of the new United Nations' global campaign is to protect health and educational facilities, and the millions of people who rely on them for healthcare and learning, from emergencies.
Womanhood definitely has its advantages—studies even show we live longer than men—but menopause isn't on the list of perks. Sometime between the ages of 40-58, our bodies will inevitably experience a drop in estrogen production and begin a metamorphosis.
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today the winners of the 13th annual Graeme Clark and the fourth annual Anders Tjellstrom Scholarships.
› Verified 1 days ago
| NPI Number | 1750576294 |
| Organization Name | NEW JERSEY CVS PHARMACY LLC |
| Doing Business As | CVS PHARMCY #00638 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 74 South Lakeview Drive, Gibbsboro, NJ 08026 |
| Phone Number | 856-783-6328 |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. reported today that top-line results from the one-year lorcaserin BLOOM-DM trial demonstrate statistically significant weight loss in obese and overweight patients with type 2 diabetes. In this trial, lorcaserin met all three co-primary efficacy endpoints. In addition, as described below, lorcaserin patients taking lorcaserin 10 mg twice daily (BID) achieved statistically significant improvements in multiple secondary endpoints, including HbA1c, as compared to patients randomized to placebo.
A new model based on measuring stress from daily hassles may help forecast future migraine headache attacks in those who develop them frequently.
The World Health Organization is pledging its support to the One Million Safe Schools and Hospitals Campaign launched yesterday in Manila. The goal of the new United Nations' global campaign is to protect health and educational facilities, and the millions of people who rely on them for healthcare and learning, from emergencies.
Womanhood definitely has its advantages—studies even show we live longer than men—but menopause isn't on the list of perks. Sometime between the ages of 40-58, our bodies will inevitably experience a drop in estrogen production and begin a metamorphosis.
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today the winners of the 13th annual Graeme Clark and the fourth annual Anders Tjellstrom Scholarships.
› Verified 1 days ago
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. reported today that top-line results from the one-year lorcaserin BLOOM-DM trial demonstrate statistically significant weight loss in obese and overweight patients with type 2 diabetes. In this trial, lorcaserin met all three co-primary efficacy endpoints. In addition, as described below, lorcaserin patients taking lorcaserin 10 mg twice daily (BID) achieved statistically significant improvements in multiple secondary endpoints, including HbA1c, as compared to patients randomized to placebo.
A new model based on measuring stress from daily hassles may help forecast future migraine headache attacks in those who develop them frequently.
The World Health Organization is pledging its support to the One Million Safe Schools and Hospitals Campaign launched yesterday in Manila. The goal of the new United Nations' global campaign is to protect health and educational facilities, and the millions of people who rely on them for healthcare and learning, from emergencies.
Womanhood definitely has its advantages—studies even show we live longer than men—but menopause isn't on the list of perks. Sometime between the ages of 40-58, our bodies will inevitably experience a drop in estrogen production and begin a metamorphosis.
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today the winners of the 13th annual Graeme Clark and the fourth annual Anders Tjellstrom Scholarships.
› Verified 1 days ago
Cvs Pharmacy #00638 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 74 Lakeview Dr S, Gibbsboro, New Jersey 08026 Phone: (856) 783-6328 |